This map shows the geographic impact of D. J. Norman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. J. Norman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. J. Norman more than expected).
This network shows the impact of papers produced by D. J. Norman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. J. Norman. The network helps show where D. J. Norman may publish in the future.
Co-authorship network of co-authors of D. J. Norman
This figure shows the co-authorship network connecting the top 25 collaborators of D. J. Norman.
A scholar is included among the top collaborators of D. J. Norman based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with D. J. Norman. D. J. Norman is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
17 of 17 papers shown
1.
Çobanoğlu, Adnan, et al.. (1998). Squamous and basal cell carcinoma in heart transplant recipients.. PubMed. 17(6). 586–91.59 indexed citations
Hershberger, Ray E., et al.. (1994). The specificity of normal qualitative angiography in excluding cardiac allograft vasculopathy.. PubMed. 13(1 Pt 1). 142–8; discussion 148.14 indexed citations
4.
Kimball, Jess, D. J. Norman, Charles F. Shield, et al.. (1993). OKT3 antibody response study: comparative testing of human antimouse antibody.. PubMed. 25(2 Suppl 1). 74–6.6 indexed citations
5.
Hershberger, Ray E., et al.. (1992). Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids.. PubMed. 11(2 Pt 1). 367–9.88 indexed citations
Norman, D. J.. (1989). The Clinical Role of OKT3. Immunology and Allergy Clinics of North America. 9(1). 95–107.5 indexed citations
8.
Shield, Charles F., et al.. (1989). The human antimouse reaction to OKT3: cross-reactive pattern analysis using a large group of anti-CD3 and isotypic monoclonal antibodies.. PubMed. 21(1 Pt 1). 981–4.3 indexed citations
Norman, D. J., et al.. (1985). A preliminary analysis of a randomized study of buffy coat transfusions in renal transplantation. 17(6). 2330–2332.2 indexed citations
12.
Chou, Szu‐Yi & D. J. Norman. (1985). Effect of OKT3 antibody therapy on cytomegalovirus reactivation in renal transplant recipients. 17(6). 2755–2756.11 indexed citations
13.
Norman, D. J., et al.. (1985). Blood transfusions are beneficial in HLA-identical siblings kidney transplants. 17(6). 2347–2348.3 indexed citations
14.
Norman, D. J., et al.. (1985). Natural history of patients who make cytotoxic antibodies following prospective fresh blood transfusions. 17. 1041–1043.2 indexed citations
15.
Norman, D. J., John M. Barry, & Karen Henell. (1985). Reversal of acute allograft rejection with monoclonal antibody. 17. 39–41.21 indexed citations
16.
Norman, D. J., et al.. (1985). OKT3 for treatment of acute and steroid- and ATG-resistant acute rejection in renal allograft transplantation. 17(6). 2744–2747.6 indexed citations
17.
Carpenter, Charles B., et al.. (1979). Evidence for a second class II (Ia) antigenic system in rats linked to RT1.. PubMed. 11(3). 1582–3.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.